Great Lakes Advisors LLC Has $15.06 Million Holdings in Amedisys Inc (AMED)

Share on StockTwits

Great Lakes Advisors LLC decreased its stake in Amedisys Inc (NASDAQ:AMED) by 12.7% in the first quarter, HoldingsChannel reports. The institutional investor owned 122,143 shares of the health services provider’s stock after selling 17,822 shares during the period. Great Lakes Advisors LLC’s holdings in Amedisys were worth $15,056,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of AMED. First Hawaiian Bank increased its position in Amedisys by 45.6% in the fourth quarter. First Hawaiian Bank now owns 415 shares of the health services provider’s stock worth $49,000 after buying an additional 130 shares in the last quarter. Financial Gravity Companies Inc. bought a new position in shares of Amedisys in the fourth quarter worth about $50,000. Meeder Asset Management Inc. boosted its stake in shares of Amedisys by 107.4% in the fourth quarter. Meeder Asset Management Inc. now owns 477 shares of the health services provider’s stock worth $56,000 after acquiring an additional 247 shares during the period. Captrust Financial Advisors boosted its stake in shares of Amedisys by 161.8% in the fourth quarter. Captrust Financial Advisors now owns 597 shares of the health services provider’s stock worth $70,000 after acquiring an additional 369 shares during the period. Finally, Group One Trading L.P. bought a new position in shares of Amedisys in the fourth quarter worth about $90,000. Institutional investors and hedge funds own 91.71% of the company’s stock.

In related news, insider David B. Pearce sold 4,370 shares of the stock in a transaction that occurred on Tuesday, March 12th. The stock was sold at an average price of $120.01, for a total transaction of $524,443.70. Following the completion of the transaction, the insider now directly owns 13,129 shares of the company’s stock, valued at $1,575,611.29. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Jeffrey A. Rideout sold 1,411 shares of the stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $121.58, for a total value of $171,549.38. Following the transaction, the director now directly owns 4,557 shares of the company’s stock, valued at $554,040.06. The disclosure for this sale can be found here. Over the last three months, insiders have sold 18,281 shares of company stock valued at $2,160,243. 2.90% of the stock is owned by corporate insiders.

AMED has been the subject of a number of recent analyst reports. Zacks Investment Research raised Amedisys from a “hold” rating to a “buy” rating and set a $151.00 price objective for the company in a research note on Thursday, February 7th. SunTrust Banks upped their price objective on Amedisys to $145.00 and gave the stock a “buy” rating in a research note on Friday, March 1st. BidaskClub lowered Amedisys from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 28th. ValuEngine lowered Amedisys from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, February 27th. Finally, Barclays upped their price objective on Amedisys from $115.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Thursday, March 21st. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and five have issued a buy rating to the stock. Amedisys has a consensus rating of “Hold” and a consensus price target of $125.90.

NASDAQ AMED opened at $108.34 on Friday. The stock has a market capitalization of $3.47 billion, a PE ratio of 29.85, a price-to-earnings-growth ratio of 1.35 and a beta of 1.33. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.91 and a quick ratio of 0.91. Amedisys Inc has a twelve month low of $71.74 and a twelve month high of $140.91.

Amedisys (NASDAQ:AMED) last announced its quarterly earnings results on Tuesday, April 30th. The health services provider reported $1.11 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.22. Amedisys had a return on equity of 28.25% and a net margin of 7.14%. The company had revenue of $467.34 million during the quarter, compared to analyst estimates of $460.83 million. During the same period in the prior year, the company earned $0.79 earnings per share. The firm’s revenue was up 17.0% on a year-over-year basis. Equities research analysts predict that Amedisys Inc will post 4.08 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Great Lakes Advisors LLC Has $15.06 Million Holdings in Amedisys Inc (AMED)” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.tickerreport.com/banking-finance/4346660/great-lakes-advisors-llc-has-15-06-million-holdings-in-amedisys-inc-amed.html.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, social workers, and aides for its patients to complete their important personal tasks.

See Also: How is inflation measured?

Want to see what other hedge funds are holding AMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amedisys Inc (NASDAQ:AMED).

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

China Shenhua Energy –  to Issue $0.42 Annual Dividend
China Shenhua Energy – to Issue $0.42 Annual Dividend
Wall Financial Co.  Plans Dividend Increase – $2.00 Per Share
Wall Financial Co. Plans Dividend Increase – $2.00 Per Share
Guaranty Bancshares, Inc.  Declares Quarterly Dividend of $0.17
Guaranty Bancshares, Inc. Declares Quarterly Dividend of $0.17
Bancolombia SA  To Go Ex-Dividend on June 26th
Bancolombia SA To Go Ex-Dividend on June 26th
Vail Resorts, Inc.  Announces $1.76 Quarterly Dividend
Vail Resorts, Inc. Announces $1.76 Quarterly Dividend
Dynex Capital Inc Announces Monthly Dividend of $0.18
Dynex Capital Inc Announces Monthly Dividend of $0.18


© 2006-2019 Ticker Report